Publications
View and download slide summaries of the latest original articles focusing on cytokine signalling therapies within rheumatoid arthritis. All materials produced by the CSF team are subsequently reviewed and approved by individual Steering Committee members.
May 2023
細胞を標的とした生物学的製剤またはJAK阻害薬で治療中の関節リウマチ患者におけるアジュバント添加リコンビナント帯状疱疹ワクチンの免疫原性と安全性: 前向き観察研究
Int JMol Sci 2023;24(8):6967 doi 10.3390/ijms24086967
A prospective observational study showed that recombinant zoster vaccine (RZV) immunogenicity is not impaired in RA patients on JAK inhibitors or anti-cellular bDMARDs.